Pages with the fewest revisions

From IDWiki

Showing below up to 50 results in range #1 to #50.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Dominant R-wave in V1‏‎ (1 revision)
  2. CR:DOI:61f25230a048dc543296b3bbc6d6baea‏‎ (1 revision)
  3. Tachyphylaxis‏‎ (1 revision)
  4. Ochrobactrum anthropi‏‎ (1 revision)
  5. Lenvatinib‏‎ (1 revision)
  6. HLA-DR3‏‎ (1 revision)
  7. CR:DOI:6cf032b3d733b8eafe7627257ce067d8‏‎ (1 revision)
  8. Bands‏‎ (1 revision)
  9. Thomasclavelia ramosa‏‎ (1 revision)
  10. Tick bite prevention‏‎ (1 revision)
  11. CR:DOI:85b8b38f010838c55c8dd50923ee4b2b‏‎ (1 revision)
  12. Pacemakers‏‎ (1 revision)
  13. MATRix‏‎ (1 revision)
  14. Hepatomegaly‏‎ (1 revision)
  15. CR:DOI:9333507aa0777a2dcb0ad6ece486f2c4‏‎ (1 revision)
  16. Traumatic brain injury‏‎ (1 revision)
  17. Hip bursa injection‏‎ (1 revision)
  18. Ciclopirox‏‎ (1 revision)
  19. CR:DOI:9ef9380ff28aaf3a7e23bddbd8f5667e‏‎ (1 revision)
  20. Acute bacterial prostatitis‏‎ (1 revision)
  21. Hyperaldosteronism‏‎ (1 revision)
  22. CR:DOI:afb3d02bc01ad3adc6010f37c10a92c3‏‎ (1 revision)
  23. Acute labyrinthitis‏‎ (1 revision)
  24. Hypoglycorrhachia‏‎ (1 revision)
  25. Extracorporeal life support‏‎ (1 revision)
  26. Colchicine‏‎ (1 revision)
  27. CR:DOI:bc7f64d0251e73e5b7f31169b9aa0e5c‏‎ (1 revision)
  28. CR:DOI:0829a713e95cbbd4b450ed29b107c622‏‎ (1 revision)
  29. Model for end-stage liver disease‏‎ (1 revision)
  30. CR:DOI:c6b0b2592ddf24cc5b656bbc4bbc13b2‏‎ (1 revision)
  31. CR:DOI:105c5ac67b92f84c60065a20abf33855‏‎ (1 revision)
  32. Alcaligenes‏‎ (1 revision)
  33. Vasopressors and inotropes‏‎ (1 revision)
  34. Moya moya syndrome‏‎ (1 revision)
  35. Fibrinogen‏‎ (1 revision)
  36. CR:DOI:d0a6ae27f8da47002a176a60aae6a653‏‎ (1 revision)
  37. CR:DOI:1e05c9fa81f92bdccea40e74e189de3b‏‎ (1 revision)
  38. Sickle cell crisis‏‎ (1 revision)
  39. CR:DOI:d7e82ec5e5ad23fe3de0c2225396c4f1‏‎ (1 revision)
  40. CR:DOI:28a4b106e551cfcb14890dfc07c9ad0c‏‎ (1 revision)
  41. WBC scan‏‎ (1 revision)
  42. Myelodysplastic disorders‏‎ (1 revision)
  43. Infliximab‏‎ (1 revision)
  44. CR:DOI:e7d5997f6ba302aad44373195ab7f4fa‏‎ (1 revision)
  45. CR:DOI:35deea6bca62469c53a8d1db72080a12‏‎ (1 revision)
  46. Spontaneous breathing trial‏‎ (1 revision)
  47. Post-transfusion purpura‏‎ (1 revision)
  48. Nasal septal perforation‏‎ (1 revision)
  49. Debaryomyces hansenii‏‎ (1 revision)
  50. CR:DOI:f02e515a07b7b94afb259db5668e8149‏‎ (1 revision)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)